These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 11562153

  • 21. Effects of an antiandrogenic oral contraceptive on appetite and eating behavior in bulimic women.
    Naessén S, Carlström K, Byström B, Pierre Y, Hirschberg AL.
    Psychoneuroendocrinology; 2007 Jun; 32(5):548-54. PubMed ID: 17475412
    [Abstract] [Full Text] [Related]

  • 22. Identity impairment and the eating disorders: content and organization of the self-concept in women with anorexia nervosa and bulimia nervosa.
    Stein KF, Corte C.
    Eur Eat Disord Rev; 2007 Jan; 15(1):58-69. PubMed ID: 17676674
    [Abstract] [Full Text] [Related]

  • 23. Observations favouring the occurrence of local production and marked effects of bombesin/gastrin-releasing peptide in the synovial tissue of the human knee joint--comparisons with substance P and the NK-1 receptor.
    Grimsholm O, Rantapää-Dahlqvist S, Dalén T, Forsgren S.
    Neuropeptides; 2008 Apr; 42(2):133-45. PubMed ID: 18289674
    [Abstract] [Full Text] [Related]

  • 24. Role of bombesin-related peptides in the control of food intake.
    Merali Z, McIntosh J, Anisman H.
    Neuropeptides; 1999 Oct; 33(5):376-86. PubMed ID: 10657515
    [Abstract] [Full Text] [Related]

  • 25. Contribution of CNS neuropeptide (NPY, CRH, and beta-endorphin) alterations to psychophysiological abnormalities in anorexia nervosa.
    Kaye WH, Berrettini WH, Gwirtsman HE, Gold PW, George DT, Jimerson DC, Ebert MH.
    Psychopharmacol Bull; 1989 Oct; 25(3):433-8. PubMed ID: 2533990
    [Abstract] [Full Text] [Related]

  • 26. Corticotropin-releasing hormone: possible role in eating disorders.
    Krahn DD, Gosnell BA.
    Psychiatr Med; 1989 Oct; 7(4):235-45. PubMed ID: 2690192
    [Abstract] [Full Text] [Related]

  • 27. Cerebrospinal fluid peptide YY immunoreactivity in eating disorders.
    Berrettini WH, Kaye WH, Gwirtsman H, Allbright A.
    Neuropsychobiology; 1988 Oct; 19(3):121-4. PubMed ID: 3200408
    [Abstract] [Full Text] [Related]

  • 28. Effectiveness of day hospital treatment for anorexia nervosa and bulimia nervosa.
    Fittig E, Jacobi C, Backmund H, Gerlinghoff M, Wittchen HU.
    Eur Eat Disord Rev; 2008 Sep; 16(5):341-51. PubMed ID: 18668700
    [Abstract] [Full Text] [Related]

  • 29. Should bulimia nervosa be subtyped by history of anorexia nervosa? A longitudinal validation.
    Eddy KT, Dorer DJ, Franko DL, Tahilani K, Thompson-Brenner H, Herzog DB.
    Int J Eat Disord; 2007 Nov; 40 Suppl():S67-71. PubMed ID: 17610249
    [Abstract] [Full Text] [Related]

  • 30. Altered ghrelin and peptide YY responses to meals in bulimia nervosa.
    Kojima S, Nakahara T, Nagai N, Muranaga T, Tanaka M, Yasuhara D, Masuda A, Date Y, Ueno H, Nakazato M, Naruo T.
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):74-8. PubMed ID: 15638873
    [Abstract] [Full Text] [Related]

  • 31. Hypothalamic digoxin, hemispheric chemical dominance, and eating behavior.
    Kurup RK, Kurup PA.
    Int J Neurosci; 2003 Aug; 113(8):1127-41. PubMed ID: 12888426
    [Abstract] [Full Text] [Related]

  • 32. Eating Disorders Examination versus Eating Disorders Examination-Questionnaire in adolescents with full and partial-syndrome bulimia nervosa and anorexia nervosa.
    Binford RB, Le Grange D, Jellar CC.
    Int J Eat Disord; 2005 Jan; 37(1):44-9. PubMed ID: 15690465
    [Abstract] [Full Text] [Related]

  • 33. Bulimia nervosa in adolescents: a disorder in evolution?
    le Grange D, Loeb KL, Van Orman S, Jellar CC.
    Arch Pediatr Adolesc Med; 2004 May; 158(5):478-82. PubMed ID: 15123482
    [Abstract] [Full Text] [Related]

  • 34. Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa.
    Kaye W, Gendall K, Strober M.
    Biol Psychiatry; 1998 Nov 01; 44(9):825-38. PubMed ID: 9807638
    [Abstract] [Full Text] [Related]

  • 35. Measurement of CSF dynorphin A 1-8 immunoreactivity in anorexia nervosa and normal-weight bulimia.
    Lesem MD, Berrettini WH, Kaye WH, Jimerson DC.
    Biol Psychiatry; 1991 Feb 01; 29(3):244-52. PubMed ID: 1673064
    [Abstract] [Full Text] [Related]

  • 36. Are neuropeptides important in arthritis? Studies on the importance of bombesin/GRP and substance P in a murine arthritis model.
    Grimsholm O, Guo Y, Ny T, Rantapää-Dahlqvist S, Forsgren S.
    Ann N Y Acad Sci; 2007 Sep 01; 1110():525-38. PubMed ID: 17911468
    [Abstract] [Full Text] [Related]

  • 37. Obsessive-compulsive characteristics in women who have recovered from bulimia nervosa.
    Morgan JC, Wolfe BE, Metzger ED, Jimerson DC.
    Int J Eat Disord; 2007 May 01; 40(4):381-5. PubMed ID: 17286246
    [Abstract] [Full Text] [Related]

  • 38. Investigation of peptide YY and ghrelin responses to a test meal in bulimia nervosa.
    Monteleone P, Martiadis V, Rigamonti AE, Fabrazzo M, Giordani C, Muller EE, Maj M.
    Biol Psychiatry; 2005 Apr 15; 57(8):926-31. PubMed ID: 15820714
    [Abstract] [Full Text] [Related]

  • 39. Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP).
    Nakagawa T, Hocart SJ, Schumann M, Tapia JA, Mantey SA, Coy DH, Tokita K, Katsuno T, Jensen RT.
    Biochem Pharmacol; 2005 Feb 15; 69(4):579-93. PubMed ID: 15670577
    [Abstract] [Full Text] [Related]

  • 40. Smoking in eating disorders.
    Anzengruber D, Klump KL, Thornton L, Brandt H, Crawford S, Fichter MM, Halmi KA, Johnson C, Kaplan AS, LaVia M, Mitchell J, Strober M, Woodside DB, Rotondo A, Berrettini WH, Kaye WH, Bulik CM.
    Eat Behav; 2006 Nov 15; 7(4):291-9. PubMed ID: 17056404
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.